Related references
Note: Only part of the references are listed.Transthyretin familial amyloid polyneuropathy: an update
Violaine Plante-Bordeneuve
JOURNAL OF NEUROLOGY (2018)
Transthyretin Mimetics as Anti--Amyloid Agents: AComparison of Peptide and Protein Approaches
Kayla M. Pate et al.
CHEMMEDCHEM (2018)
Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future
Jeffrey Cummings et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
The Rationale Behind the New Alzheimer's Disease Conceptualization: Lessons Learned During the Last Decades
Jose Luis Molinuevo et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Prospects for dementia research
Geoff Watts
LANCET (2018)
Stabilizing Transthyretin to Treat ATTR Cardiomyopathy
C. Cristina Quarta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes
Jeffrey Cummings
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)
Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015
Dev Mehta et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Cerebrospinal Fluid Proteins as Regulators of Beta-amyloid Aggregation and Toxicity
Kayla M. Pate et al.
ISRAEL JOURNAL OF CHEMISTRY (2017)
Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial
Merce Boada et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Atomic-resolution map of the interactions between an amyloid inhibitor protein and amyloid β(Aβ) peptides in the monomer and protofibril states
Moustafa Algamal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Targeting Apolipoprotein E/Amyloid β Binding by Peptoid CPO_Aβ17-21 P Ameliorates Alzheimer's Disease Related Pathology and Cognitive Decline
Shan Liu et al.
SCIENTIFIC REPORTS (2017)
Transthyretin stability is critical in assisting beta amyloid clearance- Relevance of transthyretin stabilization in Alzheimer's disease
Mobina Alemi et al.
CNS NEUROSCIENCE & THERAPEUTICS (2017)
CSF, blood-brain barrier, and brain drug delivery
William M. Pardridge
EXPERT OPINION ON DRUG DELIVERY (2016)
TTR kinetic stabilizers and TTR gene silencing: a new era in therapy for familial amyloidotic polyneuropathies
David Adams et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Clusterin Binds to A1-42 Oligomers with High Affinity and Interferes with Peptide Aggregation by Inhibiting Primary and Secondary Nucleation
Marten Beeg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity
Ricardo Sant'Anna et al.
NATURE COMMUNICATIONS (2016)
Transthyretin participates in beta-amyloid transport from the brain to the liver-involvement of the low-density lipoprotein receptor-related protein 1?
Mobina Alemi et al.
SCIENTIFIC REPORTS (2016)
Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis
Teresa Coelho et al.
NEUROLOGY AND THERAPY (2016)
Positron Emission Tomography: Current Challenges and Opportunities for Technological Advances in Clinical and Preclinical Imaging Systems
Juan Jose Vaquero et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 17 (2015)
Transthyretin Stabilization by Iododiflunisal Promotes Amyloid-beta Peptide Clearance, Decreases its Deposition, and Ameliorates Cognitive Deficits in an Alzheimer's Disease Mouse Model
Carlos A. Ribeiro et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro
Roberta Cascella et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Tafamidis (Vyndaqel): A Light for FAP Patients
Susanna Nencetti et al.
CHEMMEDCHEM (2013)
Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy
Kazuaki Taguchi et al.
LIFE SCIENCES (2013)
Transthyretin Decrease in Plasma of MCI and AD Patients: Investigation of Mechanisms for Disease Modulation
Carlos A. Ribeiro et al.
Current Alzheimer Research (2012)
TTR Fibril Formation Inhibitors: Is there a SAR?
S. Nencetti et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Stability of the Transthyretin Molecule as a Key Factor in the Interaction with A-Beta Peptide - Relevance in Alzheimer's Disease
Carlos A. Ribeiro et al.
PLOS ONE (2012)
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade
Christine E. Bulawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Transthyretin: roles in the nervous system beyond thyroxine and retinol transport
Sandra Marisa Oliveira et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2012)
Structure and function of the blood-brain barrier
N. Joan Abbott et al.
NEUROBIOLOGY OF DISEASE (2010)
124I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of 131I-L19-SIP radioimmunotherapy
Bernard M. Tijink et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Iodine Atoms: A New Molecular Feature for the Design of Potent Transthyretin Fibrillogenesis Inhibitors
Teresa Mairal et al.
PLOS ONE (2009)
Transthyretin binding to A-Beta peptide - Impact on A-Beta fibrillogenesis and toxicity
R. Costa et al.
FEBS LETTERS (2008)
Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aβ toxicity
Joel N. Buxbaum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Role of transthyretin in thyroxine transfer from cerebrospinal fluid to brain and choroid plexus
Nouhad A. Kassem et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: A focus on the transthyretin amyloidoses
SM Johnson et al.
ACCOUNTS OF CHEMICAL RESEARCH (2005)
Human transthyretin in complex with iododiflunisal: structural features associated with a potent amyloid inhibitor
L Gales et al.
BIOCHEMICAL JOURNAL (2005)
Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors
I Dolado et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2005)
Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative
MR Almeida et al.
BIOCHEMICAL JOURNAL (2004)
Transthyretin fibrillogenesis entails the assembly of monomers:: A molecular model for in vitro assembled transthyretin amyloid-like fibrils
I Cardoso et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Improved radioiodination of biomolecules using exhaustive chloramine-t oxidation
AM Robles et al.
NUCLEAR MEDICINE AND BIOLOGY (2001)
Transthyretin amyloidosis: a tale of weak interactions
MJM Saraiva
FEBS LETTERS (2001)
Share Paper
